Seeing Is Believing
Currently out of the existing stock ratings of Sachin Jain, 1 are a HOLD (5.56%), 16 are a BUY (88.89%), 1 are a SELL (5.56%).
Analyst Sachin Jain, currently employed at BAML, carries an average stock price target met ratio of 75% that have a potential upside of 39.89% achieved within 674 days. Previously, Sachin Jain worked at DEUTSCHE BANK.
Sachin Jain’s has documented 27 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AZN, AstraZeneca PLC ADR at 25-Nov-2025.
Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for AZN (ASTRAZENECA PLC ADR) at 9/29/2021. The price target of $138.8 was fulfilled within 561 days with a profit of $31.24 (29.04%) receiving and performance score of 0.52.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 02-Dec-2019
$105
$-83.41 (-44.27%)
$95
9 months 25 days ago
(09-Dec-2025)
0/13 (0%)
$-72.77 (-40.93%)
Buy Since 05-Sep-2023
$108.5
$-79.91 (-42.41%)
$91.7
10 months 9 days ago
(25-Nov-2025)
1/6 (16.67%)
$-76.04 (-41.21%)
483
Hold Since 27-Oct-2025
11 months 7 days ago
(27-Oct-2025)
3/6 (50%)
$14.33 (11.16%)
782
Buy Since 30-May-2024
$97
1 years 6 months 4 days ago
(30-Mar-2025)
0/2 (0%)
$-43.8 (-31.11%)
Hold Since 12-Feb-2025
1 years 7 months 22 days ago
(12-Feb-2025)
7/11 (63.64%)
$120.33 (100.53%)
675
What Year was the first public recommendation made by Sachin Jain?